Item 8.01 Other Information.
Adjournment of Meeting
On September 14, 2021, Organovo Holdings, Inc. (the “Company”) commenced the Company’s 2021 Annual Meeting of Stockholders (the “Annual Meeting”), as previously scheduled for Tuesday, September 14, 2021 at 9:00 a.m. (Pacific Daylight Time), and adjourned the Annual Meeting without any business being conducted until to 9:00 a.m. (Pacific Daylight Time) on Tuesday, October 5, 2021, due to lack of a quorum. The Annual Meeting was adjourned to allow the Company’s stockholders additional time to vote on the proposals described in the Company’s proxy statement for the Annual Meeting.
Stockholders will be able to attend the reconvened Annual Meeting virtually at www.virtualshareholdermeeting.com/ONVO2021. Stockholders who have already voted do not need to recast their votes. Proxies previously submitted in respect of the Annual Meeting will be voted at the adjourned Annual Meeting unless properly revoked. During the period of the adjournment, the Company continues to solicit votes from its stockholders with respect to the proposals for the Annual Meeting. The Company encourages all stockholders who have not yet voted to do so before Monday, October 4, 2021 at 11:59 p.m., Eastern Time.
The close of business on July 19, 2021 will continue to be the record date for the determination of stockholders of the Company entitled to vote at the Annual Meeting.
On September 17, 2021, the Company issued a press release announcing the adjournment of the Annual Meeting. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Supplemental Disclosures to the Proxy Statement
On August 5, 2021, the Company filed with the Securities and Exchange Commission a definitive proxy statement (the “Original Filing”) in connection with the solicitation of proxies by the Company for the Annual Meeting and filed a supplement to the Original Filing on August 31, 2021 (the “Supplement” and the Original Filing, as amended by the Supplement, the “Proxy Statement”).
This Current Report on Form 8-K (this “Form 8-K”) is being filed to update and supplement the Proxy Statement. The information contained in this Form 8-K amends and is incorporated by reference into the Proxy Statement. Terms used in this Form 8-K but not otherwise defined shall have the meanings ascribed to such terms in the Proxy Statement. Except as specifically supplemented or amended by the information contained in this Form 8-K, all information in the Proxy Statement remains accurate and should be considered in voting your shares.
Item 9.01 Financial Statements and Exhibits.
